In This Issue
Pets at Home to close all seven of its Barkers high street stores
Sainsbury’s extends pet range with new food launch
Pet food firms could do more to tackle plastic waste
£1.5m new investment at Inspired Pet Nutrition site
New technology firm gets funding for its pet product
UK pet food manufacturer raises the bar on traceability
HOWND offers savings on Valentine's Day orders
Pet food firm launches new franchise business
New tray format to appeal to smaller dogs
Fish4Dogs pledges support for Cinnamon Trust charity
News from around the stands at BETA International 2018
Get your own copy of Pet Trade Xtra
Skinner's appoints new Managing Director
Aquatics wholesaler gets set to close
Last chance to nominate for Ceva Animal Welfare Awards
Photizo lights up 35th Aviemore Sled Dog Rally
Xtra Dog to become sponsor of the Agilitynet Winners Out Certificate
Problem Indicator helps owners to find solutions to health problems
IPN strengthens commercial team
Veteran Charlie gets back in harness to win Gold
The best of the previous Pet Trade Xtra
High street pet store in danger of closure
Private equity firm invests in growing pet business
Pet firm named in Top 100 franchise list
Big success predicted for Little BigPaw in 2018
Find out how Pet Trade Xtra can help to promote your business and products.

Please contact for all editorial matters.

Email to discuss advertising and sponsorship opportunities.
Private equity firm invests in growing pet business

Inflexion Private Equity announced this week that it has invested in Lintbells Limited, a leading producer of nutritional supplements for pets.


Founded in 2006, Lintbells is now the leading pet supplements company in the UK, including two key brands: YuMOVE, the number one joint mobility supplement for dogs and cats, and YuMEGA, the UK’s number one supplement for skin and coat.


Lintbells has growing international businesses in Asia and Europe.


The UK market for pet supplements is worth approximately £100m and is growing at 7% per annum as pet owners become more aware of the existence and effectiveness of such products.


With an immature and fragmented market, there is significant scope for Lintbells to scale further. There is also the opportunity to launch new products, enhance Lintbells’ existing digital presence and continue its international expansion.


Inflexion can draw on its experience in the pet-care market, having already invested in Medivet, the UK’s largest independent operator of veterinary practices, and Kynetec, the primary provider of market data to companies operating in this sector. 


Tim Smallbone, Head of the Enterprise Fund, Inflexion, commented, “We are delighted to have partnered with such a strong and motivated management team. The business is well placed to accelerate its already impressive growth in both the UK and internationally, with significant investment and R&D underpinning Lintbells’ prospects.”


John Howie, CEO & Co-founder of Lintbells, said: “We are excited to have brought on board a true partner whose international presence and sector expertise will be invaluable as we work together to drive Lintbells’ growth.


"We knew we had found the right partner when the Inflexion team showed the ability to quickly understand our business and what drives it. It made the process move incredibly swiftly.


"We look forward to working closely with them as Lintbells attracts new customers, launches new products, and enters new geographies.”


The Inflexion deal team comprised Tim Smallbone, Ben Long and Robin Senivassen. Ben Long will join the board on completion.


This deal was made by affiliated funds advised by Inflexion Private Equity Partners LLP.

Facebook Twitter LinkedIn